Prof. Jamal Sabir | Nanomedicine Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Jamal Sabir | Nanomedicine Awards | Best Researcher Award

Prof. Jamal Sabir , King Abdulaziz University , Saudi Arabia

Jamal Sabir M Sabir, a Saudi Arabian native born in Taif, holds a distinguished academic background. He earned his Bachelor’s degree in Biology (Zoology) from King Abdulaziz University in 1980, followed by a Master’s degree in Biology (Genetics) from the same institution in 1984. His academic journey culminated in a Ph.D. in Genetics and Biotechnology from Sussex University, UK, in 1992. Dr. Sabir’s career progression reflects his dedication to academia, starting as a Demonstrator at King Abdulaziz University in 1980 and rising to the rank of Professor in 2014. His scientific pursuits encompass diverse areas, including the induction of genetic mutations, genotoxicity studies of pesticides and heavy metals, and biotechnology research. Dr. Sabir has supervised numerous postgraduate projects, focusing on mutagenic effects, cytogenetics, molecular evaluations, and genomic analyses. His contributions extend to bioremediation efforts for oil pollutants and the molecular genetic study of human breast cancer. Dr. Sabir’s extensive scientific activities underscore his commitment to advancing genetic research and biotechnology in Saudi Arabia and beyond.

Professional Profile:

Scopus

Education:

Jamal Sabir M Sabir earned his Bachelor’s degree in Biology (Zoology) from King Abdulaziz University in Saudi Arabia in 1980. He continued his studies at the same institution, obtaining a Master’s degree in Biology (Genetics) in 1984. Dr. Sabir then pursued his Ph.D. in Genetics and Biotechnology at Sussex University in Brighton, UK, completing it in 1992

Work Experience:

Dr. Jamal Sabir M Sabir’s career at King Abdulaziz University in Saudi Arabia began in 1980 when he was appointed as a Demonstrator in the Faculty of Science. He advanced to the position of Lecturer in 1986. In 1992, Dr. Sabir was promoted to Assistant Professor, followed by a promotion to Associate Professor in 2001. His academic achievements and dedication to research and teaching led to his promotion to full Professor in 2014.

Publication Top Notes:

  • Synthesis of biocomposites from microalgal peptide incorporated polycaprolactone/κ-carrageenan nanofibers and their antibacterial and wound healing property
    • Authors: Raghunathan, S., Kandasamy, S., Balakrishna Pillai, A., Kim, J.-W., Davoodbasha, M.
    • Journal: International Journal of Pharmaceutics, 2024
  • Synthesis and characterization of hydroxy propyl methyl Cellulose/Copper nanobiocomposites for antibacterial and antioxidant smart materials
    • Authors: Davoodbasha, M., Raghunathan, S., Mohammed Yasin, A., Lee, S.-Y., Kim, J.-W.
    • Journal: Journal of Molecular Liquids, 2024
  • Identification and Characterization of HIRIP3 as a Histone H2A Chaperone
    • Authors: Ignatyeva, M., Patel, A.K.M., Ibrahim, A., Sabir, J.S.M., Hamiche, A.
    • Journal: Cells, 2024
  • Next generation sequencing shows diversity of Omicron sub-lineages of SARS-COV2 circulating in Jeddah, Saudi Arabia
    • Authors: Bouna, A., Atef, A., Al-Mahdi, H.B., Rather, I.A., Sabir, J.S.M.
    • Journal: Journal of King Saud University – Science, 2024
  • MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density
    • Authors: Papin, C., Ibrahim, A., Sabir, J.S.M., Bronner, C., Hamiche, A.
    • Journal: Journal of Experimental and Clinical Cancer Research, 2023
    • Citations: 1

 

 

Lorena García Hevia | Nanomedicine | Best Researcher Award

Posted on by ScienceFather

Dr. Lorena García Hevia | Nanomedicine | Best Researcher Award

Dr. Lorena García Hevia, Universidad de Cantabria, Spain

👩‍🔬 Dr. Lorena García Hevia, a distinguished biologist and established researcher at the University of Cantabria, Spain, specializes in nanomedicine and molecular biology. Awarded the prestigious Ramon y Cajal contract, she holds expertise in cancer-focused nanotechnology, earning recognition for her exceptional doctoral thesis. With an international research background, including roles in the USA, Portugal, and Italy, she contributes significantly to cancer treatment advancements. Leading multiple projects and supervising theses, Dr. García Hevia actively engages in research networks, conferences, and science outreach events, emphasizing her commitment to scientific excellence and knowledge dissemination. 🌐🔬🏆

🎓 Education & Experience:

📜 R3 certified established researcher, young at 40 years old. 🎓 Master’s (2011) and Ph.D. (2016) in Molecular Biology and Biomedicine from the University of Cantabria (UC). 🏆 “Premio Extraordinario” and “Premio Juan María Parés” for the best doctoral thesis in Health Sciences at UC. 🌐 International experience in nanomedicine research at institutions in Europe and the USA. 🌍 Positions at the University of Oklahoma, International Nanotechnology Laboratory (INL) in Portugal, and The Biorobotics Institute in Italy. 🧪 Specialization in cancer research using gold nanoparticles and magnetic nanostructures.

🏆 Achievements:

🎗️ Awarded the prestigious Spanish Ramon y Cajal contract. 🤝 Associated researcher at Valdecilla Research Institute (IDIVAL). 🏆 Leadership role as co-chair of the organizing committee for the NALS 2022 Congress. 📄 31 publications, h-index: 14, 506 citations (Scopus).

🔬 Areas of Research:

🩺 Nanomedicine. 🧬 Molecular and Cell Biology.

🚀 Research & Development Contributions:

🌐 Involved in over 15 National and International projects. 🏅 Leading four projects, including a National Health project and a Strategic Project for Ecological and Digital Transition. 🎓 Supervising 5 Ph.D. theses, 3 Master final projects, and 6 Degree final projects. 🌐 Participation in 35+ National and International congresses. 🤝 Membership in various research networks and associations, including NANOCARE 2.0, Spanish Association for Cancer Research, European Association for Cancer Research, Controlled Release Society, and Research Network NANOMED Spain.

💬 Communication and Outreach:

🌍 Engaged in dissemination activities like “International Day of Women in Science,” “CONOCELAS,” and “European Research Night”. 🤝 Leadership role as co-chair of the organizing committee for the NALS 2022 Congress showcases dedication to community involvement and collaboration.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 659.
  • Citations – 659.
  • h-index – 16.
  • Documents – 45.

A prolific researcher making meaningful contributions to the academic world!

🔬 Research Focus:

Dr. Lorena García Hevia’s groundbreaking research in nanomedicine revolves around developing innovative multifunctional nanocarriers. Her work includes the design of graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery, cited 71 times in 2018. She delves into the impact of nano-ZnO on cytoskeletal structures, triggering cell necrosis (71 citations, 2016). Exploring manganese-based nanostructures as responsive MRI contrast agents (66 citations, 2019), her contributions extend to the therapeutic realm, inhibiting tumor progression (39 citations, 2016) and cancer cell migration (35 citations, 2015). Her research reflects a diverse portfolio, from investigating nanotube interactions with microtubules (32 citations, 2014) to the recent synergy of magnetic lipid nanovehicles for controlled thermal release and non-invasive monitoring in melanoma (27 citations, 2022). 🌐🔬

Publications Top Note: